Logo image of DLTH

DULUTH HOLDINGS INC - CL B (DLTH) Stock Fundamental Analysis

NASDAQ:DLTH - Nasdaq - US26443V1017 - Common Stock - Currency: USD

2.31  -0.01 (-0.43%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DLTH. DLTH was compared to 122 industry peers in the Specialty Retail industry. DLTH has a bad profitability rating. Also its financial health evaluation is rather negative. DLTH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year DLTH has reported negative net income.
DLTH had a negative operating cash flow in the past year.
In multiple years DLTH reported negative net income over the last 5 years.
In multiple years DLTH reported negative operating cash flow during the last 5 years.
DLTH Yearly Net Income VS EBIT VS OCF VS FCFDLTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

DLTH has a Return On Assets of -11.02%. This is in the lower half of the industry: DLTH underperforms 78.69% of its industry peers.
DLTH's Return On Equity of -30.44% is on the low side compared to the rest of the industry. DLTH is outperformed by 63.93% of its industry peers.
Industry RankSector Rank
ROA -11.02%
ROE -30.44%
ROIC N/A
ROA(3y)-3.75%
ROA(5y)-0.57%
ROE(3y)-9.12%
ROE(5y)-1.44%
ROIC(3y)N/A
ROIC(5y)N/A
DLTH Yearly ROA, ROE, ROICDLTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

Looking at the Gross Margin, with a value of 49.01%, DLTH is in the better half of the industry, outperforming 77.87% of the companies in the same industry.
In the last couple of years the Gross Margin of DLTH has declined.
DLTH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.04%
GM growth 5Y-1.57%
DLTH Yearly Profit, Operating, Gross MarginsDLTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

2

2. Health

2.1 Basic Checks

DLTH does not have a ROIC to compare to the WACC, probably because it is not profitable.
DLTH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DLTH has more shares outstanding
DLTH has about the same debt/assets ratio as last year.
DLTH Yearly Shares OutstandingDLTH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DLTH Yearly Total Debt VS Total AssetsDLTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

DLTH has an Altman-Z score of 1.59. This is a bad value and indicates that DLTH is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DLTH (1.59) is worse than 64.75% of its industry peers.
DLTH has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DLTH (0.32) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 1.59
ROIC/WACCN/A
WACC9.72%
DLTH Yearly LT Debt VS Equity VS FCFDLTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

DLTH has a Current Ratio of 1.35. This is a normal value and indicates that DLTH is financially healthy and should not expect problems in meeting its short term obligations.
DLTH has a Current ratio (1.35) which is comparable to the rest of the industry.
DLTH has a Quick Ratio of 1.35. This is a bad value and indicates that DLTH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DLTH (0.22) is worse than 86.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.22
DLTH Yearly Current Assets VS Current LiabilitesDLTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

1

3. Growth

3.1 Past

The earnings per share for DLTH have decreased strongly by -93.66% in the last year.
DLTH shows a decrease in Revenue. In the last year, the revenue decreased by -4.21%.
Measured over the past years, DLTH shows a small growth in Revenue. The Revenue has been growing by 0.36% on average per year.
EPS 1Y (TTM)-93.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-4.21%
Revenue growth 3Y-3.56%
Revenue growth 5Y0.36%
Sales Q2Q%-11.98%

3.2 Future

DLTH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.80% yearly.
The Revenue is expected to decrease by -5.68% on average over the next years.
EPS Next Y-14.29%
EPS Next 2Y16.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.52%
Revenue Next 2Y-5.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DLTH Yearly Revenue VS EstimatesDLTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
DLTH Yearly EPS VS EstimatesDLTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DLTH. In the last year negative earnings were reported.
Also next year DLTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DLTH Price Earnings VS Forward Price EarningsDLTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DLTH Per share dataDLTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as DLTH's earnings are expected to grow with 16.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.8%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DLTH!.
Industry RankSector Rank
Dividend Yield N/A

DULUTH HOLDINGS INC - CL B

NASDAQ:DLTH (7/25/2025, 8:00:01 PM)

2.31

-0.01 (-0.43%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)06-05 2025-06-05/bmo
Earnings (Next)08-27 2025-08-27/bmo
Inst Owners24.6%
Inst Owner Change0.32%
Ins Owners27.86%
Ins Owner Change11.17%
Market Cap86.81M
Analysts47.5
Price Target2.04 (-11.69%)
Short Float %2.22%
Short Ratio5.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-58.25%
Min EPS beat(2)-138.06%
Max EPS beat(2)21.57%
EPS beat(4)2
Avg EPS beat(4)-13.79%
Min EPS beat(4)-138.06%
Max EPS beat(4)86.93%
EPS beat(8)2
Avg EPS beat(8)-154.25%
EPS beat(12)4
Avg EPS beat(12)-111.9%
EPS beat(16)8
Avg EPS beat(16)-20.43%
Revenue beat(2)0
Avg Revenue beat(2)-5.95%
Min Revenue beat(2)-6.46%
Max Revenue beat(2)-5.45%
Revenue beat(4)1
Avg Revenue beat(4)-3.19%
Min Revenue beat(4)-7.58%
Max Revenue beat(4)6.71%
Revenue beat(8)1
Avg Revenue beat(8)-2.82%
Revenue beat(12)2
Avg Revenue beat(12)-2.84%
Revenue beat(16)4
Avg Revenue beat(16)-1.82%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)47.73%
EPS NY rev (1m)0%
EPS NY rev (3m)37.98%
Revenue NQ rev (1m)-1.8%
Revenue NQ rev (3m)0.55%
Revenue NY rev (1m)-1.59%
Revenue NY rev (3m)-0.93%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.52
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-1.27
FCFYN/A
OCF(TTM)-1.06
OCFYN/A
SpS16.3
BVpS4.47
TBVpS4.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.02%
ROE -30.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.01%
FCFM N/A
ROA(3y)-3.75%
ROA(5y)-0.57%
ROE(3y)-9.12%
ROE(5y)-1.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.04%
GM growth 5Y-1.57%
F-Score2
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.43%
Cap/Sales 1.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.22
Altman-Z 1.59
F-Score2
WACC9.72%
ROIC/WACCN/A
Cap/Depr(3y)84.18%
Cap/Depr(5y)65.82%
Cap/Sales(3y)4.14%
Cap/Sales(5y)3.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-93.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-14.29%
EPS Next 2Y16.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.21%
Revenue growth 3Y-3.56%
Revenue growth 5Y0.36%
Sales Q2Q%-11.98%
Revenue Next Year-11.52%
Revenue Next 2Y-5.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-145.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year133.15%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-69.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-427.67%
OCF growth 3YN/A
OCF growth 5YN/A